معرفی
Maria Ebbesen Sørum is a Postdoc researcher at the Department of Biomedical Sciences, specifically within the Endocrinology and Metabolism research group at the University of Copenhagen's Faculty of Health and Medical Sciences. Her research focuses on endocrine and metabolic aspects of pediatric hematopoietic stem cell transplantation, with particular attention to long-term outcomes for survivors.
Her primary research interests include:
- Endocrine complications following stem cell transplantation
- Metabolic syndrome in long-term survivors of pediatric hematopoietic stem cell transplantation
- Role of growth factors (particularly IGF-1) in transplantation outcomes
- GLP-1 and metabolic regulation in pediatric transplant patients
- Nutritional aspects of post-transplant care
- Biomarkers for transplant-related complications
Analysis of her recent publications (2021-2025) reveals a strong focus on metabolic and endocrine consequences of pediatric hematopoietic stem cell transplantation. Her work spans several key areas including growth factor regulation, metabolic syndrome development, nutritional deficiencies, and exploration of potential therapeutic interventions like semaglutide. A notable trend is her investigation of biomarkers that can predict or monitor transplant-related complications such as sinusoidal obstruction syndrome and graft-versus-host disease.
Scientific contributions:
- 9 research outputs in the last five years (8 journal articles, 1 comment/debate)
- Active collaboration with researchers across multiple disciplines including endocrinology, hematology, and immunology
- Participation in clinical trial design (PROTECT study)
- Work cited across multiple platforms including X, Bluesky, and academic readership sites
Dr. Sørum appears to be actively involved in collaborative research, with multiple co-authored publications involving interdisciplinary teams. Her work contributes significantly to understanding and improving long-term outcomes for pediatric patients undergoing hematopoietic stem cell transplantation, addressing critical gaps in knowledge regarding metabolic health in this vulnerable population.
